133 related articles for article (PubMed ID: 11094587)
1. Urinary, biliary and faecal excretion of rocuronium in humans.
Proost JH; Eriksson LI; Mirakhur RK; Roest G; Wierda JM
Br J Anaesth; 2000 Nov; 85(5):717-23. PubMed ID: 11094587
[TBL] [Abstract][Full Text] [Related]
2. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study.
Staals LM; Snoeck MM; Driessen JJ; van Hamersvelt HW; Flockton EA; van den Heuvel MW; Hunter JM
Br J Anaesth; 2010 Jan; 104(1):31-9. PubMed ID: 20007792
[TBL] [Abstract][Full Text] [Related]
3. Effects of hypothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium.
Smeulers NJ; Wierda JM; van den Broek L; Gallandat Huet RC; Hennis PJ
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):700-5. PubMed ID: 8664462
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.
van Miert MM; Eastwood NB; Boyd AH; Parker CJ; Hunter JM
Br J Clin Pharmacol; 1997 Aug; 44(2):139-44. PubMed ID: 9278198
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients.
Sparr HJ; Wierda JM; Proost JH; Keller C; Khuenl-Brady KS
Br J Anaesth; 1997 Mar; 78(3):267-73. PubMed ID: 9135303
[TBL] [Abstract][Full Text] [Related]
6. Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates.
Kleef UW; Proost JH; Roggeveld J; Wierda JM
J Chromatogr; 1993 Nov; 621(1):65-76. PubMed ID: 8308088
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis.
Khalil M; D'Honneur G; Duvaldestin P; Slavov V; De Hys C; Gomeni R
Anesthesiology; 1994 Jun; 80(6):1241-7. PubMed ID: 8010470
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children.
Wierda JM; Meretoja OA; Taivainen T; Proost JH
Br J Anaesth; 1997 Jun; 78(6):690-5. PubMed ID: 9215021
[TBL] [Abstract][Full Text] [Related]
9. Hypothermic cardiopulmonary bypass influences the concentration-response relationship and the biodisposition of rocuronium.
Smeulers NJ; Wierda JM; van den Broek L; Gallandat Huet RC; Hennis PJ
Eur J Anaesthesiol Suppl; 1995 Sep; 11():91-4. PubMed ID: 8557015
[TBL] [Abstract][Full Text] [Related]
10. Newer neuromuscular blocking agents: how do they compare with established agents?
Sparr HJ; Beaufort TM; Fuchs-Buder T
Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of rocuronium during the three stages of liver transplantation.
Fisher DM; Ramsay MA; Hein HA; Marcel RJ; Sharma M; Ramsay KJ; Miller RD
Anesthesiology; 1997 Jun; 86(6):1306-16. PubMed ID: 9197300
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.
McCoy EP; Mirakhur RK; Maddineni VR; Wierda JM; Proost JH
Br J Anaesth; 1996 Jan; 76(1):29-33. PubMed ID: 8672375
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacodynamic modeling without plasma concentrations of rocuronium in children.
Velázquez-Armenta EY; Nava-Ocampo AA
J Clin Pharmacol; 2002 Jan; 42(1):37-42. PubMed ID: 11808822
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
[TBL] [Abstract][Full Text] [Related]
15. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.
Wierda JM; Kleef UW; Lambalk LM; Kloppenburg WD; Agoston S
Can J Anaesth; 1991 May; 38(4 Pt 1):430-5. PubMed ID: 1829656
[TBL] [Abstract][Full Text] [Related]
16. Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone.
Driessen JJ; Robertson EN; Booij LH; Vree TB
Br J Anaesth; 1998 Mar; 80(3):386-8. PubMed ID: 9623443
[TBL] [Abstract][Full Text] [Related]
17. Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography-tandem mass spectroscopy.
Gutteck-Amsler U; Rentsch KM
Clin Chem; 2000 Sep; 46(9):1413-4. PubMed ID: 10973876
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of rocuronium bromide in obese female patients.
Pühringer FK; Keller C; Kleinsasser A; Giesinger S; Benzer A
Eur J Anaesthesiol; 1999 Aug; 16(8):507-10. PubMed ID: 10500937
[TBL] [Abstract][Full Text] [Related]
19. Is neuromuscular relaxation of rocuronium prolonged in patients with obstructive jaundice?
Wang Z; Bao Y; Lu Z; Yu W
Med Hypotheses; 2011 Jan; 76(1):100-1. PubMed ID: 20832951
[TBL] [Abstract][Full Text] [Related]
20. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries.
Costa ACC; Coelho EB; Lanchote VL; Correia BV; Abumansur JT; Lauretti GR; de Moraes NV
Eur J Clin Pharmacol; 2017 Aug; 73(8):957-963. PubMed ID: 28409297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
